← All trials
NCT04027322
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2019
- Primary completion
- May 30, 2020
- Completion date
- Aug 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 300
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Oman Medical Board Specialty (OMSB)Lead sponsor
- Oman Medical Board Specialty (OMSB)Reponsible party - principal investigator
- Oman Medical Board Specialty (OMSB)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.